Drug Pricing Bill: Senate Sponsors ‘Not Backing Down’ From Inflation Rebates
Price inflation rebates are the linchpin of the legislation’s Democratic support, Sen. Chuck Grassley, R-IA, argues. But to many Republicans, they sound too much like price controls.
You may also be interested in...
Results of an analysis published in JAMA could undercut arguments against legislative proposals establishing inflation penalties in Medicare.
“We’re out of time for ideas," Domestic Policy Council Director Joe Grogan says. Trump administration is pushing hard to get the Senate drug pricing bill through Congress quickly and score a major victory for the President.
Former drug pricing advisor John O’Brien discusses next steps for Administration policies around importation and international reference pricing during a speech to the Academy of Managed Care Pharmacy.